LED Medical Inc. Announces Partnership Between LED Dental Ltd. and
Ray Co., Ltd., a Subsidiary of Samsung
BURNABY, BRITISH COLUMBIA--(Marketwired - Apr 3, 2014) - LED
Medical Diagnostics Inc.
(TSX-VENTURE:LMD)(OTCQX:LEDIF)(FRANKFURT:LME) ("LED Medical" or the
"Company") announced today that LED Imaging, the new dental imaging
division of its wholly-owned operating subsidiary, LED Dental Ltd.
("LED Dental") has partnered with Ray Co., Ltd. ("Ray Co."), a
subsidiary of Samsung, to sell, install and provide support for the
RAYSCAN α - Expert dental imaging system.
The RAYSCAN α - Expert is a multi-function digital extraoral
imaging system with 3D cone beam computed tomography (CBCT),
panoramic and cephalometric capabilities. Ray Co. is the first
partner to join LED Imaging's product portfolio since the company
announced its expansion into the dental imaging category and
emergent product offerings.
"We are very excited about working with Ray Co. and Samsung to
provide practitioners with a compact, yet powerful, CBCT imaging
system to capture the crisp, high-quality images needed for
diagnosis and treatment," said Lamar Roberts, president of LED
Imaging. "We understand what practitioners want and need, so
partnerships like this give us an advantage to provide the best
technology available in each product category."
The RAYSCAN α - Expert's 3D images are captured using an optimal
9 cm x 9 cm field of view, which is ideal for a wide variety of
clinical applications. The system's CMOS and Direct Deposition
Cesium Iodide (CsI) Detector ensure practitioners can quickly
capture high-quality, 16-bit DICOM images at a low radiation dose.
To minimize error from patient positioning and movement, the
system's focal trough is stabilized and controlled through Adaptive
Moving Focus technology. The RAYSCAN α's exclusive denoising
technology enhances image quality by removing noise that would
otherwise blur the image.
Due to its sleek design, the RAYSCAN α - Expert can fit into
nearly any practice floor plan. The system's height adjustment
component means patients of all sizes, including those in
wheelchairs, can fit comfortably in the unit. The RAYSCAN α -
Expert is also the world's first imaging system to utilize a
wireless remote control for patient positioning. Additionally,
green, blue, yellow and red LED lights indicate the status of the
unit to practitioners at a glance: ready, standby, exposure and
emergency. These components led to the RAYSCAN α - Expert receiving
both the red dot design award and International Design Excellence
Bronze Award for its effective product design.
In addition to the RAYSCAN α - Expert's advanced imaging
capabilities and unique design, the system also features an
intuitive user interface to streamline the capture process and
simplify the manipulation of images. The system utilizes Xelis 3D
Imaging Software, which features state-of-the art functionality and
a comprehensive implant planning module.
"With the legal close of our business partnership with LED
Imaging, we're one step closer to bringing oral health
practitioners a strong manufacturer that offers greater dental
products and access to more services in the U.S. market," said Dr.
Sangchul Lee, CEO of Ray Co. "As such, we're proud to align our
product with the LED Imaging brand due to its solid leadership team
with both clinical and industry experience."
Ray Co. is Samsung's first subsidiary business venture in the
dental technology industry. Samsung is a worldwide leader in
technology and electronics. LED Imaging will offer nationwide
service and technical support for the RAYSCAN α - Expert. To learn
more about LED Imaging, visit www.leddental.com.
About Ray Co., Ltd., a Subsidiary of Samsung
Since 2004, Ray Co., Ltd., has specialized in researching,
developing and producing high-quality 3D computed tomography
systems for the medical and dental industries. Due to outstanding
x-ray technology development, Ray Co. became a subsidiary of
worldwide technology leader SAMSUNG Electronics Co., Ltd, in 2010.
With Samsung's full support on design, manufacturing and quality
management, Ray Co. launched the RAYSCAN α - Expert in 2012. The
company strives for differentiation in the dental industry through
relentless R&D to deliver imaging products based on a unique
design concept: simple + smart + emotional.
About LED Dental Ltd.
Based in Atlanta, Ga., LED Dental Ltd. is a wholly‐owned
subsidiary of LED Medical Diagnostics Inc. Backed by an experienced
leadership team dedicated to a higher level of service and support,
LED Dental offers advanced diagnostic imaging equipment that
seamlessly integrates into dental practices. The Company is
committed to providing dental practitioners with the best
technology available by identifying and adding strong products to
its growing portfolio. Additionally, the company manufactures the
award-winning VELscope® Vx Enhanced Oral Assessment System, the
first system in the world to apply tissue fluorescence
visualization technology to the oral cavity. The VELscope® Vx is
now used to conduct more screenings for oral cancer and other oral
diseases than any other adjunctive device. For more information,
call 888.541.4614 or visit
www.leddental.com.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia,
Canada, LED Medical Diagnostics Inc. is a leading developer of
LED‐based visualization technologies for the medical industry. The
Company is currently listed on the Toronto Stock Exchange (TSX‐V)
under the symbol "LMD," the OTCQX under the symbol "LEDIF," as well
as the Frankfurt Stock Exchange under the symbol "LME." For more
information, visit www.ledmd.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This press release contains statements which, to the extent
that they are not recitations of historical fact, may constitute
forward-looking information under applicable Canadian securities
legislation that involve risks and uncertainties. Such
forward-looking statements or information include statements
regarding, but not limited to the Company's future distribution
strategy and product offerings and the potential expansion of the
Company's technology to other medical applications or markets, or
the potential introduction of new technologies to the Company.
Persons reading this press release are cautioned that such
statements or information are only predictions, and that the
Corporation's actual future results or performance may be
materially different. Factors that could cause actual events or
results to differ materially from those suggested by these
forward-looking statements include, but are not limited to
competition risks, distributor risks, product development risks
such as regulatory, design, intellectual property and other factors
described in the Corporation's reports filed on SEDAR including its
Annual Information Form and financial report for the year ended
December 31, 2012. These and other factors should be considered
carefully and readers should not place undue reliance on such
forward-looking information. All forward-looking statements made in
this press release are qualified by this cautionary statement and
there can be no assurance that actual results or developments
anticipated by the Company will be realized. The Company disclaims
any intention or obligation to update or revise forward-looking
information, whether as a result of new information, future events
or otherwise, except as required by law.
For media or investor relations: LED ImagingChris
Koch404.502.4438chris.koch@leddental.comwww.leddental.comLED
Medical Diagnostics Inc.Mark Komonoski, Investor
Relations403.255-8483 or Toll-Free: 877.255.8483Cell:
403.470.8384mark.komonoski@ledmd.comSkype: mkomonoski
Grafico Azioni LED Medical Diagnostics (TSXV:LMD)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni LED Medical Diagnostics (TSXV:LMD)
Storico
Da Feb 2024 a Feb 2025
